Evidence map›Paper›PMID 40429493›Full record

ReviewJournal of clinical medicine2025

Prosthetic Heart Valves: More than Half a Century of Innovation-An Overview.

Asna Tabassum, Katherine G Phillips, Fadi Hage, Ali Hage

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Asna TabassumDepartment of Cardiothoracic Surgery, NYU Langone Medical Center, New York, NY 10016, USA.
Katherine G PhillipsDepartment of Cardiothoracic Surgery, NYU Langone Medical Center, New York, NY 10016, USA.ORCID 0000-0001-8257-0899
Fadi HageLankenau Medical Center, Wynnewood, PA 19096, USA.
Ali HageDepartment of Cardiothoracic Surgery, NYU Langone Medical Center, New York, NY 10016, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since Dr. Charles Hufnagel introduced the first ball-in-cage valve prosthesis in 1952 to treat a patient with aortic regurgitation, the field of valvular heart disease has undergone remarkable evolution in both prosthetic valve development and patient management. Over the past 73 years, a wide range of valvular prostheses have been developed, each offering distinct advantages in terms of durability, thrombogenicity, and hemodynamics. This review aims to provide a detailed discussion of commonly known and used valvular heart prostheses, along with a review of newer endovascular prostheses. As ongoing research and innovation continue to shape the field, we can expect further improvements in hemodynamics, clinical outcomes, cost, ease of operation, and patient quality of life.

Indexed as

cardiac surgerymechanical valvesprosthetic valvestranscatheter valve replacementvalve innovationvalve replacementvalvular heart disease

Identifiers

PMID40429493
PMCPMC12112632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.